SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-024279
Filing Date
2019-05-07
Accepted
2019-05-07 17:01:32
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv519830_10q.htm 10-Q 852753
2 EXHIBIT 31.1 tv519830_ex31-1.htm EX-31.1 11648
3 EXHIBIT 31.2 tv519830_ex31-2.htm EX-31.2 11730
4 EXHIBIT 32.1 tv519830_ex32-1.htm EX-32.1 4499
5 EXHIBIT 32.2 tv519830_ex32-2.htm EX-32.2 4563
12 GRAPHIC tv519830_img01.jpg GRAPHIC 81499
  Complete submission text file 0001144204-19-024279.txt   7349456

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT iova-20190331.xml EX-101.INS 2186805
7 XBRL TAXONOMY EXTENSION SCHEMA iova-20190331.xsd EX-101.SCH 40650
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iova-20190331_cal.xml EX-101.CAL 30853
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iova-20190331_def.xml EX-101.DEF 309108
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20190331_lab.xml EX-101.LAB 324952
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20190331_pre.xml EX-101.PRE 350146
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 19804003
SIC: 2836 Biological Products, (No Diagnostic Substances)